Sign in

Foster Dykema Cabot & Partners, LLC

CIK:0002011882
Investment Adviser
$2B AUM
340 holdings
Waltham, MA, United States
Founded:1967
18 employees
Latest filing:Jun 30, 2025

Foster Dykema Cabot & Partners, LLC is a Waltham, MA-based private wealth management and investment advisory firm founded via the acquisition of a business established in 1967. It serves high-net-worth individuals, families, trusts, estates, pension plans, and certain non-profit entities, offering services that include investment management, financial planning, family office, and trust administration. The firm, a wholly owned subsidiary of Focus Financial Partners, manages nearly $2 billion in assets and employs around 18 professionals, including eight investment advisors. Their client base primarily consists of high-net-worth private clients and select institutional investors.

Investment Strategy

Foster Dykema Cabot & Partners implements discretionary, long-term portfolio management for high-net-worth individuals and families. The firm emphasizes strategic asset allocation, investing mainly in publicly traded equities, bonds, mutual funds, and ETFs, with select access for qualified clients to private equity and private real estate funds via pooled investment vehicles. Portfolios are actively managed, monitored continuously, and periodically rebalanced. The firm avoids short-term trading, aiming to generate attractive, after-tax, risk-adjusted returns. For private investments, FDC seeks managers with established track records and applies substantial due diligence.

Latest 13F Filing Activity

Foster Dykema Cabot & Partners, LLC filed their most recent 13F report on Jun 30, 2025 disclosing 339 equity positions with a total 13F market value of $1B. The fund increased holdings in JP Morgan Usd Ultrashort Income Etf, SPDR S&P 500 Etf Trust, Amphenol Corporation Class A among other positions. Foster Dykema Cabot & Partners, LLC reduced exposure to Thermo Fisher Scientific Inc., Berkshire Hathaway Inc. Class B, Vertex Pharmaceuticals Incorporated among others.

Top Buys
J
JPSTJP Morgan USD UltraShort Income ETF
+$57.5M
S
SPYSPDR S&P 500 ETF Trust
+$23.5M
A
APHAmphenol Corporation Class A
+$19.9M
P
PWRQuanta Services Com
+$14.4M
M
MSFTMicrosoft Corporation
+$13.9M
Top Sells
T
TMOThermo Fisher Scientific Inc.
-$4.1M
B
BRK-BBerkshire Hathaway Inc. Class B
-$2.7M
V
VRTXVertex Pharmaceuticals Incorporated
-$2.7M
L
LLYEli Lilly and Company
-$2.1M
I
ICSHiShares Ultra Short Duration Bond Active ETF
-$1.5M

Top Holdings

S
SPYSPDR S&P 500 ETF Trust
+18.2%$259.1M
J
JPSTJP Morgan USD UltraShort Income ETF
+13.6%$193.3M
I
ICSHiShares Ultra Short Duration Bond Active ETF
+7.9%$112.6M
A
APHAmphenol Corporation Class A
+4.2%$60.0M
M
MSFTMicrosoft Corporation
+3.9%$55.7M

Equity Positions (339)

TickerSecurityWeightMarket ValueSharesAvg CostPriceChange (QoQ)
SPDR S&P 500 ETF Trust18.22%$259.1M418,128$476.99$617.85+$23.5M
JP Morgan USD UltraShort Income ETF13.60%$193.3M3,814,842$50.40$50.68+$57.5M
iShares Ultra Short Duration Bond Active ETF7.92%$112.6M2,220,761$50.41$50.71-$1.5M
Amphenol Corporation Class A4.22%$60.0M606,215$50.59$98.75+$19.9M
Microsoft Corporation3.91%$55.7M111,885$381.36$497.41+$13.9M

Industry Allocation

SERVICES-PREPACKAGED SOFTWARE
+5.7%
ELECTRONIC CONNECTORS
+4.9%
SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC.
+3.7%
RETAIL-CATALOG & MAIL-ORDER HOUSES
+3.5%
PHARMACEUTICAL PREPARATIONS
+3.4%

Investment Team (4)

NameRoleLocationLinkedIn
Edward Terwilliger
Edward Terwilliger
Senior Investment Analyst and Head TraderBoston, MA , United States
V
Vikram Soorma
Partner, Portfolio ManagerWaltham, MA , United States
E
Ed Terwilliger
Senior Investment Analyst and Head TraderBoston, MA , United States
Jeff McGrew
Jeff McGrew
Chief Investment OfficerBoston, MA , United States